Visualize HL7 Example and Test Instances (vi7eti), pronounced /viːˈsɛtiː/
Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on on healthcare or medicines. The web pages are not kept up to date and are for demonstration purposes only. For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine. For up-to-date information on other healthcare topics, please consult the relevant reliable sources or an healthcare expert, such as a physician etc.
 BACK TO LIST

European Patient Summary

Patient
Name: Varela, Rosario
DOB: 03-MAY-1956 (Age: 69)
Gender: male
ID: 8295-992682-3 (ECI)
Author
dr Dávila, Socorro
Patient summary Document
European Patient Summary
Report Date: 07-JUN-2025

Problem list

Condition Onset Date / Period Status
Osteoporosis 17-Dec-2022 active
Ischemic heart disease 01-Sep-2007 active
Hyperlipidemia 20-Jul-1996 active
Substance dependence 21-Apr-1996 active
Metabolic syndrome X 09-Jul-1994 active
Anemia 22-Jun-1991 active
Impacted molars 25-Sep-1990 active
Chronic intractable migraine without aura 05-Feb-1990 active
Obstructive sleep apnea syndrome 10-Feb-1982 active
Sleep disorder 18-Jan-1982 active
Essential hypertension 02-Apr-1977 active
Streptococcal sore throat 26-May-2025 - 08-Jun-2025 inactive
Acute infective cystitis 03-Jul-2023 - 05-Jul-2023 inactive
Sprain of ankle 05-Dec-2022 - 26-Dec-2022 inactive
Whiplash injury to neck 24-Jul-2016 - 24-Sep-2016 inactive
Injury of neck 24-Jul-2016 - 24-Sep-2016 inactive

Medication list

Medication Since Form Dosage Reason
Hydrochlorothiazide 25 mg oral tablet 2025-06-07 - 1 tablet (25 mg) by mouth once daily Essential hypertension (disorder)
Lisinopril 10 mg oral tablet 2025-06-07 - 1 tablet (10 mg) by mouth once daily Essential hypertension (disorder)
Alendronic acid (as alendronate sodium) 10 mg oral tablet 2025-06-07 - 1 tablet (10 mg) once daily Osteoporosis (disorder)
Simvastatin 10 mg oral tablet 2024-12-29 - 1 tablet (10 mg) by mouth once daily Hyperlipidemia
Clopidogrel (as clopidogrel bisulfate) 75 mg oral tablet 2007-09-08 - 1 tablet (75 mg) by mouth once daily -
Simvastatin 20 mg oral tablet 2007-09-08 - 1 tablet (20 mg) by mouth once daily -
Nitroglycerin 400 microgram/actuation sublingual spray 2007-09-08 - 400 micrograms (1 spray) under the tongue as needed for chest pain, may repeat every 5 minutes as needed, up to 3 sprays in 15 minutes -
Metoprolol tartrate (as metoprolol succinate) 100 mg prolonged-release oral tablet 2007-09-08 - 1 tablet (100 mg) once daily -

Immunizations list

Vaccine Date
Influenza virus antigen only vaccine product 28-Dec-2024
Clostridium tetani toxoid antigen adsorbed only vaccine product 23-Dec-2023
SARS-CoV-2 mRNA vaccine 01-May-2021
Streptococcus pneumoniae Danish serotype 1, 3, 4, 5, 6A, 6B, 7F, 8, 9V, 10A, 11A, 12F, 14, 15B, 18C, 19A, 19F, 22F, 23F, 33F capsular polysaccharide antigens conjugated only vaccine product 24-Nov-2018
Streptococcus pneumoniae Danish serotype 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, 23F, capsular polysaccharide conjugated antigens only vaccine product 18-Nov-2017

Procedure History list

Procedure Date Reason
Patient evaluation and management 03-Jul-2023 -
Complete blood count 03-Jul-2023 -
Urine specimen collection 03-Jul-2023 -
Patient discharge 03-Jul-2023 -
Taking patient vital signs 03-Jul-2023 -
Antibiotic therapy 03-Jul-2023 -
Triage: emergency center 03-Jul-2023 -
Urinalysis with reflex to microscopy and culture 03-Jul-2023 -
Serum metabolic panel 03-Jul-2023 -
Referral to home health care service 08-Oct-2022 -
Pre-discharge assessment 24-Aug-2016 -
Discharge from hospital 24-Aug-2016 -
Nursing care/supplementary surveillance 23-Aug-2016 -
Occupational therapy 22-Aug-2016 -
Professional / ancillary services care 21-Aug-2016 -
Speech and language therapy regime 19-Aug-2016 -
Physical therapy procedure 16-Aug-2016 -
History AND physical examination 24-Jul-2016 -
Initial patient assessment 24-Jul-2016 -
Development of individualized plan of care 24-Jul-2016 -

Allergies and Intolerances

No known allergies or intolerances

Care Plan

Active Planned Care / Goals Start Date Reason
Hyperlipidemia clinical management plan 10-Aug-1996 Hyperlipidemia (disorder)
  • Achieve LDL cholesterol less than 1.8 mmol/L in patient with ischemic heart disease and metabolic syndrome.
  • Achieve total cholesterol less than 4.0 mmol/L.
  • Achieve triglycerides less than 1.7 mmol/L.
  • Achieve HDL cholesterol greater than 1.0 mmol/L.
Diabetes self management plan 22-Jun-1991 Prediabetes (finding)
  • Patient will attend diabetes self-management education sessions to improve understanding of prediabetes and lifestyle modifications.
  • Maintain fasting plasma glucose within recommended range for prediabetes.
  • Maintain HbA1c below threshold for diabetes diagnosis.
  • Achieve and maintain weight loss as recommended for prediabetes management.
Care plan 10-Feb-1982 Obstructive sleep apnea syndrome (disorder)
  • Reduce the Apnea-Hypopnea Index (AHI) to less than 5 events per hour to achieve effective control of obstructive sleep apnea.
  • Improve subjective sleep quality as reported by the patient, with fewer nighttime awakenings and increased feeling of restfulness upon waking.
  • Reduce daytime sleepiness as measured by the Epworth Sleepiness Scale to a score of less than 10.
Lifestyle education regarding hypertension 02-Apr-1977 Essential hypertension (disorder)
  • Patient will achieve and maintain blood pressure below 130/80 mmHg through lifestyle changes.
Immunization Recommendation Due Date Reason
Influenza virus antigen only vaccine product 01-Oct-2026 Annual seasonal influenza vaccination

Vital Signs

Vital Signs 2025-06-07 2025-05-26
Body Height 181.6 cm -
Pain severity - 0-10 verbal numeric rating [Score] - Reported 1 {score} -
Body Weight 91.2 kg -
Body mass index (BMI) [Ratio] 27.7 kg/m2 -
Heart rate 63 /min -
Respiratory rate 13 /min -
Blood pressure panel with all children optional 81 mm[Hg] -
Body temperature - 39.3 Cel

Relevant diagnostic tests/laboratory data

Recent Lab Observations 07-JUN-2025 Reference Range Unit
Hemoglobin A1c/Hemoglobin.total in Blood 6.2 H 4.8 - 5.9 %
Glucose [Mass/volume] in Blood 70.1 70 - 100 mg/dL
Urea nitrogen [Mass/volume] in Blood 15.5 7 - 18 mg/dL
Creatinine [Mass/volume] in Blood 0.9 0.6 - 1.3 mg/dL
Calcium [Mass/volume] in Blood 9.1 8.5 - 10.5 mg/dL
Sodium [Moles/volume] in Blood 141.3 135 - 145 mmol/L
Potassium [Moles/volume] in Blood 3.8 3.5 - 5.1 mmol/L
Chloride [Moles/volume] in Blood 110.9 H 98 - 107 mmol/L
Carbon dioxide, total [Moles/volume] in Blood 21.8 L 22 - 29 mmol/L

Device Use

Device Date (since)
Home continuous positive airway pressure unit (physical object) 11-Dec-2021
Respiratory humidifier (physical object) 11-Dec-2021
Blood glucose meter (physical object) 22-Jun-1991